Table 1.
Patient characteristics.
| Variables | Normal group (N = 250) | CAD group (N = 680) | SA group (N = 339) | ACS group (N = 341) |
|---|---|---|---|---|
| Male (n (%)) | 110 (44.0%) | 435 (64.0%)∗∗∗ | 177 (52.2%)∗ | 259 (75.7%)∗∗∗††† |
| Age (years) | 60.86 ± 9.69 | 66.55±11.13∗∗∗ | 66.45±9.82∗∗∗ | 66.67±12.29∗∗∗ |
| BMI (kg/m2) | 24.95 ± 3.45 | 24.41 ± 3.86 | 24.54 ± 2.87 | 24.29 ± 4.64 |
| Smoking (n (%)) | 67 (36.6%) | 282 (41.5%)∗∗∗ | 101 (29.8%) | 182 (53.2%)∗∗∗††† |
| Hypertension (n (%)) | 153 (61.2%) | 482 (70.9%)∗∗ | 255 (75.2%)∗∗∗ | 227 (66.4%)† |
| Hyperlipidaemia (n (%)) | 35 (14.0%) | 88 (12.9%) | 44 (13.1%)∗∗∗ | 44 (12.9%) |
| Diabetes [n (%)] | 55 (22.0%) | 282 (41.5%)∗∗∗ | 181 (53.4%)∗∗∗ | 101 (29.5%)∗††† |
| TC (mmol/L) | 4.36 ± 0.95 | 4.44 ± 1.08 | 4.35 ± 1.15 | 5.67 ± 22.09 |
| LDL-C (mmol/L) | 2.57 ± 0.80 | 2.69 ± 0.94 | 2.59 ± 0.96 | 2.79±0.91∗∗†† |
| HDL-C (mmol/L) | 1.22 ± 0.32 | 1.11±0.31∗∗∗ | 1.14±0.32∗∗ | 1.08±0.30∗∗∗†† |
| Non-HDL-C (mmol/L) | 3.15 ± 0.89 | 3.31 ± 1.08∗ | 3.21 ± 1.13 | 4.58 ± 22.05 |
| Non-HDL/HDL | 2.76 ± 1.04 | 3.20±1.32∗∗∗ | 3.04±1.35∗∗ | 3.36±1.28∗∗∗†† |
| hsCRP (mg/L) | 2.48 ± 4.51 | 12.13±22.21∗∗∗ | 4.07±6.62∗∗ | 25.17±31.71∗∗∗††† |
| TnI (μg/L) | 0.02 ± 0.06 | 10.87±26.40∗∗∗ | 0.16 ± 1.93 | 20.97±33.74∗∗∗††† |
| CK-MB (U/L) | 1.35 ± 1.02 | 34.79±80.58∗∗∗ | 2.58 ± 12.01 | 65.28±102.76∗∗∗††† |
| Pro-BNP (fmol/mL) | 249.31 ± 959.85 | 1960.34±4251.81∗∗∗ | 431.94 ± 1115.81 | 3007.99±5193.59∗∗∗††† |
| Users of statins (%) | 67 (26.8%) | 322 (47.4%)∗∗∗ | 189 (55.8%)∗∗∗ | 133 (39.0%)∗∗∗ |
CHD: coronary artery disease; SA: stable angina; ACS: acute coronary syndrome; BMI: body mass index; TC: total cholesterol; LDL-C: low-density lipoprotein cholesterol; HDL-C: high-density lipoprotein cholesterol; non-HDL-C: non-high-density lipoprotein cholesterol; non-HDL/HDL: non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio; hsCRP: high-sensitivity C-reactive protein; TnI: troponin I; CK-MB: creatine kinase isoenzyme; pro-BNP: brain natriuretic peptide. Compared with the normal group: ∗P < 0.05, ∗∗P < 0.01, and ∗∗∗P < 0.001. ACS group versus SA group: †P < 0.05, ††P < 0.01, and †††P < 0.001.